Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats

Journal of Ovarian Research

Volumn 3, Issue 1, 2010, Pages

  Priyadarshani, Anjali ^a   Chuttani, Krishna ^b   Mittal, Gaurav ^b   Bhatnagar, Aseem ^b  

^a UNIVERSITY OF DELHI   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; NOSCAPINE; NOSCAPINE TC 99M; TECHNETIUM 99M; TIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OVARY POLYCYSTIC DISEASE; PAPAVER SOMNIFERUM; PLASMA CLEARANCE; PRIORITY JOURNAL; RABBIT; RAT; REDUCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 77953449917     PISSN: None     EISSN: 17572215     Source Type: Journal    
DOI: 10.1186/1757-2215-3-10     Document Type: Article

References (33)

1. Comparison of the antitussive effects of codeine phosphate 20 mg, dextromethorphan 30 mg and noscapine 30 mg using citric acid-induced cough in normal subjects. DW Empey LA Laitinen GA Young CE Bye DT Hughes, Eur J Clin Pharmacol 1979 16 393 397 10.1007/BF00568199 527635
2. Antitussive effect of the optical isomers of mu, kappa and sigma opiate agonists/antagonists in the cat. TT Chau FE Carter LS Harris, J Pharmacol Exp Ther 1983 226 108 113 6864534
3. Martindale, the extra pharmacopoeia. A Wade, London: The Pharmaceutical Press 27 1997
4. Toxicity after large doses of noscapine. L Lasagna AH Owens BI Shnider GL Gold, Cancer Chemother Rep 1961 15 33 34 14462566
5. Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint. J Zhou D Panda JW Landen L Wilson HC Joshi, J Biol Chem 2002 277 39777 397785 10.1074/jbc.M203927200 12183452
6. Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. K Ye Y Ke N Keshava J Shanks JA Kapp RR Tekmal,, et al. Proc Natl Acad Sci 1998 95 1601 1606 10.1073/pnas.95.4.1601 9465062
7. Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma. JW Landen R Lang SJ McMahon NM Rusan AM Yvon AW Adams,, et al. Clin Cancer Res 2002 62 5187 5201
8. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation. J Zhou K Gupta S Aggarwal R Aneja R Chandra D Panda,, et al. Mol Pharmacol 2003 63 799 807 10.1124/mol.63.4.799 12644580
9. The anti-cancer activity of noscapine: a review. M Mahmoudian P Rahimi-Moghaddam, Recent Pat Anticancer Drug Discov 2009 4 92 97 10.2174/157489209787002524 19149691
10. Noscapine inhibits human prostate cancer progression and metastasis in a mouse model. I Barken J Geller M Rogosnitzky, Anticancer Res 2008 28 3701 3704 19189652
11. Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Y Ke K Ye HE Grossniklaus DR Archer HC Joshi JA Kapp, Cancer Immunol Immunother 2000 49 217 225 10.1007/s002620000109 10941904
12. Noscapine and Polycystic Ovary Syndrome: Towards a New Development. A Priyadarshani A Katyal A Bhatnagar R Chandra, Indian J Med Res 2005 Suppl February 124
13. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome. M Yilmaz A Biri A Karakoç F Toruner B Bingol N Cakir B Tiras,, et al. J Endocrinol Invest 2005 28 1003 1008 16483179 (Pubitemid 43265766)
14. Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome. S Palomba F Orio Jr A Falbo T Russo A Tolino F Zullo, J Clin Endocrinol Metab 2007 92 3498 3503 10.1210/jc.2007-1009 17595241
15. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF- and the neutrophil/lymphocyte ratio. L Ib̃ez C Valls F de Zegher, Hum Reprod 2006 21 451 456 10.1093/humrep/dei329 16239318 (Pubitemid 43159922)
16. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. A Corbould, J Endocrinol 2007 192 585 594 10.1677/joe.1.07070 17332526
17. Relevance of an opioid, noscapine in reducing cystogeneses in rat experimental model of polycystic ovary syndrome. A Priyadarshani, J Endocrinol Invest 2009 32 837 843 19609106
18. Pharmacokinetic properties of noscapine. B Dahlstrom T Mellstrand CG Lofdahl M Johansson, Eur J Clin Pharmacol 1982 22 535 539 10.1007/BF00609627 7128665
19. Pharmacokinetics of oral noscapine. MO Karlsson B Dahlstrom SA Eckernas M Johansson AT Alm, Eur J Clin Pharmacol 1990 39 275 279 10.1007/BF00315110 2257866
20. 99 mTc receptor imaging agents. B Johannsen H Spies, Transition Met Chem 1997 22 318 320 10.1023/A:1018493314473
21. Characterization of prohibitin in a newly established rat ovarian granulosa cell line. WE Thompson A Branch JA Whittaker D Lyn M Zilberstein KE Mayo,, et al. Endocrinology 2001 142 4076 4085 10.1210/en.142.9.4076 11517187
22. Lymphoscintigraphy with Tc-99m-labeled Dextran. E Henze HR Schelebert JD Collins A Najafe JR Barrio LR Benne, J Nucl Med 1982 23 923 929 6181235
23. A simplified kit for instant preparation of Technetium-99 m-Immunoglobulin-g for imaging of inflammatory foci. AK Singh P Mishra R Kashyap UPS Chauhan, Nucl Med Biol 1994 21 277 281 10.1016/0969-8051(94)90020-5 9234294
24. Tc-99m-dextran: a potential inflammation seeking radiopharmaceutical. A Bhatnagar AK Singh T Singh LR Shankar, Nucl Med Commun 1995 16 1058 1062 10.1097/00006231-199512000-00011 8719988
25. Evaluation of the efficacy of Tc-99m-Infecton, novel agent for detecting sites of infection. AV Hall KK Solanki S Vinjamuri KE Britton SS Das, J Clin Pathol 1998 51 215 219 10.1136/jcp.51.3.215 9659263
26. Evaluation of 99 mTc-ciprofloxacin scintigraphy in a rabbit model of staphylococcus aureus prosthetic joint infection. L Sarda A Saleh-Mghir C Peker,, et al. J Nucl Med 2002 43 239 245 11850491
27. Tc-99m Isoniazid: A specific agent for diagnosis of tuberculosis. AK Singh J Verma A Bhatnagar S Sen M Bose, World J Nucl Med 2003 2 292 305
28. Evidence that androgens are involved in atresia and anovulation induced by antiprogesterone RU486 in rats. JE Sanchez-Criado M Tebar A Sanchez F Gaytan, J Reprod Fertil 1993 99 173 179 8283435
29. RU486 treated rats show endocrine and morphological responses to therapies analogous to responses in women with polycystic ovary syndrome treated with similar therapies. A Ruiz R Aguilar M Tebar F Gaytan JE Sanchez-Criado, Biol Reprod 1996 55 1284 1291 10.1095/biolreprod55.6.1284 8949885
30. Technetium-99m as sodium pertechnetate. KA Lathrop HL Atkins M Berman MT Hays EM Smith, MIRD report No. 8. J Nucl Med 1976 17 74 77
31. [3H] noscapine binding sites in brain: relationship to indoleamines and the phosphoinositide and adenylyl cyclase messenger systems. RJ Mourey TM Dawson RK Barrow AE Enna SH Snyder, Mol Pharmacol 1992 42 619 626 1331753
32. Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough. A Mooraki A Jenabi M Jabbari MI Zolfaghari SZ Javanmardi M Mahmoudian,, et al. Nephrology (Carlton) 2005 10 348 350 10.1111/j.1440-1797.2005.00429.x 16109080
33. Preclinical pharmacokinetics andbioavailability of noscapine, a tubulin-binding anticancer agent. A Aneja N Dhiman J Idnani A Awasthi SK Arora R Chandra,, et al. Cancer Chemother Pharmacol 2007 60 831 839 10.1007/s00280-007-0430-y 17285314